Local application system

By using tiny protruding patches made of water-insoluble thermoplastic polymer substances with low elastic modulus, covering the drug to shorten its appearance time, solving the problem of long-term action of existing drug preparations and realizing the drug in the skin or mouth Rapid manifestation and concentration effect on mucosa.

CN119095642APending Publication Date: 2024-12-06COSMED PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380039487.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-11-11
Filing Date
2023-09-05
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing drug preparations such as local anesthesia, antihistamine, anti-inflammatory, antibacterial, pain relief and anti-itching have a long time to appear on the skin or oral mucosa, and it is difficult to achieve the effect in a short period of time.

Method used

A patch with tiny protrusions is made of water-insoluble thermoplastic polymer substance with an elastic modulus of less than 1.5×104kgf/cm2 to cover the drug, and the skin or oral mucosa is partially pulled by the compression effect of the tiny protrusions. to improve the absorption efficiency of drugs.

Benefits of technology

It significantly shortens the time when the drug's effect on the skin or oral mucosa, ensures that the drug is concentrated in the target area, avoids the drug's dispersion, and improves the drug's transmittance and application efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095642A_ABST
    Figure CN119095642A_ABST
Patent Text Reader

Abstract

Provided is a means for shortening the time for which a local anesthetic, an antihistamine, or the like, exerts an effect on the skin and oral mucosa. A microprotrusion patch which comprises a substrate and microprotrusions standing on the substrate, the substrate and the microprotrusions comprising a water-insoluble thermoplastic polymer material having an elastic modulus of 1.5 * 104 kgf / cm2 or less, and which is suitable for skin or oral mucosa; and a topical application system for shortening the acting time of a drug on the skin or oral mucosa, the topical application system comprising the microprotrusion patch and an application drug (a drug-containing gel, ointment, or the like).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a patch having micro-protrusions which are not hard enough to pierce the skin, and further to a local application system using the patch. Background Art

[0002] Although the local anesthetic preparation used to relieve pain during laser therapy is currently commercially available, it takes 40 to 60 minutes for the anesthetic effect to take effect after the preparation is applied to the skin surface. In addition, the current situation is that when a local anesthetic for application (tape containing 60% lidocaine: used to relieve pain during intravenous catheter puncture) is used for the purpose of pain relief, it also takes 60 minutes. In the treatment of insect bites, dermatitis, itching, etc., local anesthetics, antihistamines, etc. are used as drugs for external skin application to the affected area. It takes the same time for the effects of these diseases to appear.

[0003] Local anesthetics for dental use are also widely used. Although the drug is generally a (gel) ointment using lidocaine and ethyl aminobenzoate, the effect takes 10 minutes to appear, which is shorter than the effect on the skin. However, both doctors and patients require that the effect appear in a shorter time.

[0004] The inventors developed a microneedle array containing a local anesthetic for oral application and succeeded in achieving an anesthetic effect in a short time (Patent Document 1). Patent Document 1 has the following features: a local anesthetic is contained in microneedles made of a water-soluble resin.

[0005] Prior art literature

[0006] Patent Literature

[0007] Patent Document 1: Japanese Patent Application Publication No. 2019-084352 Summary of the invention

[0008] Problems to be solved by the invention

[0009] In Patent Document 1, from the perspective of a physician, a microneedle local anesthetic is administered to a patient as a manufactured pharmaceutical. In order to achieve the purpose of administering a local administration preparation including various (gel) ointments and liquids and having them exert their effects in a short period of time, a new administration method other than Patent Document 1 is necessary, which uses existing ointments and other pharmaceuticals to be appropriately prepared and used at the medical site.

[0010] The present invention is made to solve the problems related to topical preparations and aims to provide a means for shortening the time for the effects of preparations such as ointments, creams, solutions, gels and sprays for local anesthesia, antihistamines, anti-inflammatories, antibacterials, pain relief, and antipruritic effects to appear.

[0011] Means for solving problems

[0012] The present invention has the following characteristics in order to shorten the time for the effects of local anesthetics, antihistamines, anti-inflammatory agents, antibacterial agents, pain relievers, antipruritic agents, etc. on the skin and oral mucosa to manifest: when (gel) ointments or liquids containing these drugs are applied to the affected area, the applied area is covered with a patch with micro-protrusions.

[0013] As a patch with micro-protrusions, a microneedle patch is well known. The materials constituting the microneedles include silicon dioxide, metals, plastics, biosoluble substances, etc., but the existing microneedles are characterized in that they have a hardness that can pierce the skin. In the present invention, the micro-protrusions are characterized in that they have a hardness that cannot be pierced even if applied to the skin or oral mucosa. Its purpose is that although it cannot pierce the skin, the skin or oral mucosa is locally stretched and thinned by pressing the skin with micro-protrusions, thereby improving the percutaneous and permucosal absorption of the administered drug at the same time. The advantage of deliberately using a substance with poor hardness is that it can promote the percutaneous and permucosal absorption of the drug without damaging the skin.

[0014] The present invention is as follows.

[0015] [1] A microprotrusion patch applied to the skin or oral mucosa, wherein the microprotrusion patch comprises a substrate and microprotrusions arranged on the substrate.

[0016] The substrate and the micro-protrusions include a 1.5×10 4 kgf / cm 2 A water-insoluble thermoplastic polymer having an elastic modulus of the following.

[0017] [2] The microprotrusion patch according to [1], wherein the diameter of the tip of the microprotrusion is 10 μm to 300 μm, the length of the microprotrusion is 50 μm to 1500 μm, and the thickness of the substrate is 20 to 500 μm.

[0018] [3] The microprotrusion patch according to [1] or [2], wherein the water-insoluble thermoplastic polymer is selected from polyolefin, soft silicone, and polyurethane.

[0019] [4] The microprotrusion patch according to any one of [1] to [3], wherein:

[0020] The micro-protrusion patch is backed by adhesive tape.

[0021] [5] The microprotrusion patch according to [4], wherein the adhesive constituting the adhesive tape contains a hydrophilic substance.

[0022] [6] A microprotrusion patch according to [5], wherein the hydrophilic substance is at least one selected from polyacrylic acid, hyaluronic acid and its sodium salt, carboxymethyl cellulose and its sodium salt, polyvinyl alcohol, polyvinyl pyrrolidone, dextrin, sodium chondroitin sulfate, collagen, and their cross-linked products.

[0023] [7] The microprotrusion patch according to [4], wherein the adhesive substrate constituting the adhesive tape is a foam.

[0024] [8] The microprotrusion patch according to [4], wherein the adhesive substrate constituting the adhesive tape is a nonwoven fabric.

[0025] [9] A local application system for shortening the duration of action of a drug on the skin or oral mucosa, comprising the microprotrusion patch described in any one of [1] to [8] and an application drug.

[0026]

[10] The local application system according to [9], wherein the drug is a local anesthetic or an antihistamine, and the local application system is intended to achieve pain relief or itching relief in a short period of time.

[0027]

[11] The local application system according to

[10] , wherein the local anesthetic is lidocaine or ethyl aminobenzoate.

[0028]

[12] The topical application system according to

[10] , wherein the antihistamine is selected from diphenhydramine and its salts, and chlorpheniramine and its salts.

[0029] Effects of the Invention

[0030] The local application system of the present invention can shorten the time for the effects of applied drugs such as local anesthetics, antihistamines, anti-inflammatory agents, antibacterial agents, pain relievers, antipruritic agents, etc. on the skin or oral mucosa to appear. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 It is a figure which shows the microprotrusion patch which is an embodiment of this invention. Figure 1 A and Figure 1 In B, the entire back surface of the substrate of the microprotrusion patch is bonded to the adhesive tape. Figure 1 In C, a part of the back surface of the substrate of the microprotrusion patch is bonded to the adhesive tape. Figure 1 In D, the back side of the substrate of the microprotrusion patch is bonded to the adhesive foam.

[0032] Figure 2 This is a microscope photograph of the microprotrusion patch of the present invention. DETAILED DESCRIPTION

[0033] The high molecular weight material which has a hardness that cannot puncture even when applied to the skin or oral mucosa and is non-water-soluble, which is a characteristic of the present invention, has been studied. Non-water-solubility means that the micro-protrusions do not dissolve or swell even when they are in contact with the skin or oral mucosa for several minutes to tens of minutes, and is a necessary condition for the material of the present invention. When applied to the skin or mucosa, the water-soluble micro-protrusions are easily swelled and dissolved by the moisture on the surface, and while the drug diffuses toward the skin or mucosa side, it may also cause a reverse diffusion phenomenon toward the micro-protrusions. Even if a water-soluble material such as a water-soluble resin such as hyaluronic acid or carboxymethyl cellulose is used to make a micro-protrusion patch, the micro-protrusions will dissolve and lose their shape due to contact with the gel ointment, or contact with the skin or oral mucosa and due to its moisture, and thus cannot play a role in promoting penetration.

[0034] As a quantitative measure of hardness, the elastic modulus (in kgf / cm 2 ) A variety of different polymer materials were pressed into micro-protrusion patches, and the puncture resistance was evaluated by pressing on the skin. The results showed that: using a 1.5×10 4 kgf / cm 2 The following water-insoluble thermoplastic polymer materials with elastic modulus are suitable. Specifically, micro-protrusion patches containing polyolefin, soft silicone, polyurethane, etc. are suitable. The elastic modulus of various plastics measured by the inventors or confirmed from product catalogs are as follows (unit: 10 4 kgf / cm 2 ). Among polyolefins, polypropylene: 1.2, high-density polyethylene: 1.0, ethylene-vinyl acetate copolymer: 0.05. Soft silicone resin: 0.06, polyurethane resin: 0.08. These resins can be preferably used in the present invention.

[0035] Polyvinyl chloride: 3.0, polyacetal: 3.3, polyglycolic acid: 7.6, etc. are relatively hard, and the tiny protrusions made of these materials may pierce the skin, which may cause bleeding during application, and are therefore not preferred in the present invention.

[0036] By having 1.5×10 4 kgf / cm 2 In a patch of micro-protrusions made of a water-insoluble thermoplastic polymer with the following elastic modulus, the pressure of the micro-protrusions on the skin or oral mucosa stretches the outermost layer of the skin or oral mucosa (the stratum corneum in the skin), thereby making the thickness of the outermost layer thinner and improving the intradermal penetration of the drug. In addition, in the case of needle-shaped micro-protrusions, the front end of the micro-protrusions enters the shallow part of the mucosa to form micropores, thereby promoting the penetration of the drug. It is well known that the biggest barrier for drugs to penetrate the skin is the stratum corneum. If its thickness can be halved, the drug penetration will theoretically increase by 2 times.

[0037] In addition, by using the coating drug and the micro-protrusion patch at the same time, the micro-protrusion patch covers the drug and prevents the drug from flowing to the surrounding area, making it safer to apply the drug. In particular, in the case of dental surface anesthesia, if only applied, the local anesthetic is likely to flow to other parts such as the throat. By fixing it with the micro-protrusion patch, the effect of the drug can be concentrated on the target part.

[0038] Examples of dosage forms of the application drug include ointments, creams, solutions, gels, and sprays.

[0039] The present invention provides a local application system, which comprises the microprotrusion patch of the present invention and a coating drug (ointment, cream, liquid, gel or spray containing the drug), and is used to shorten the duration of action of the drug on the skin or oral mucosa. The local application system is a preparation system applied to the skin or oral mucosa, and relates to shortening the duration of the effect of preparations such as ointments, creams, liquids, gels and sprays for local anesthesia, antihistamine, anti-inflammatory, antibacterial, pain relief, antipruritic, etc.

[0040] The micro-protrusion patch includes a substrate and micro-protrusions arranged on the substrate.

[0041] The thickness of the substrate is preferably 20 to 500 μm, more preferably 50 to 300 μm. A substrate thickness of 20 μm or more is easy to handle, while a substrate thickness of 500 μm or less is easy to adhere to the oral mucosa with large irregularities.

[0042] The length of the microprotrusion is preferably 50 μm to 1500 μm, more preferably 100 μm to 1000 μm. If the length of the microprotrusion is 50 μm or more, the protrusion height is sufficient for obtaining the superficial skin thinning effect. If the length of the microprotrusion is 1500 μm or less, the microprotrusion can be prevented from bending.

[0043] In order to prevent the microprotrusion from penetrating deeply into the skin or oral mucosa when pressing the skin, the tip of the microprotrusion cannot be sharp. Therefore, the shape of the microprotrusion is preferably cylindrical, conical or truncated cone. In the case of protrusions of this shape, the diameter of the tip is preferably 10 μm or more and 300 μm or less, more preferably 30 μm to 200 μm.

[0044] As containing 1.5×10 4 kgf / cm 2 If the tip diameter of the micro-protrusions of the water-insoluble thermoplastic polymer material with an elastic modulus of less than 10 μm is greater than 10 μm, they will not penetrate deeply into the skin. If the tip diameter is less than 300 μm, sufficient concavities and convexities can be formed on the skin.

[0045] The density of microprotrusions is 20 to 1000 / cm 2 If the density is 20 pieces / cm 2 If the density is 1000 strands / cm 2 Below, the roughness of the skin can be easily revealed.

[0046] The microprotrusions are preferably produced by heat-compression bonding a thermoplastic to a concave mold, but other production methods include heat-compression bonding of a thermoplastic to a metal surface roughened by sandblasting or the like.

[0047] The area of ​​the micro-protrusion patch is equivalent to the area of ​​the substrate, and is not particularly limited, but is preferably 1 to 5 cm when used in the oral cavity. 2 .

[0048] In the micro-protrusion patch of this mode, when the medicine of coating can be reliably maintained at its position, the medicine can also be significantly improved to apply efficiency, and in the case of local anesthetics, the anesthetic effect manifestation time can be shortened. In the case of pain relief, antipruritic, the shortening of analgesia, antipruritic time etc. can be achieved. When the micro-protrusion patch is applied to skin, it is also possible to add lining by adhesive tape at the periphery, so that the patch is fixed to the skin. Although adhesive tape is not necessary, in order for the patch to be stably fixed to the skin, it is preferably fixed by adhesive tape.

[0049] The adhesive tape includes an adhesive and a substrate, and is a component obtained by applying an adhesive to a substrate. The adhesive can use rubber, silicone, acrylic, urethane adhesives, etc., but when applied to the oral mucosa, a hydrophilic adhesive is preferred. Examples of hydrophilic adhesives include: hydrophilic acrylic adhesives, HiPAS10 (trade name) adhesives (acrylic adhesives with methyl methacrylate as the main monomer, CosMED Pharmaceuticals), and HiPAS-PU (trade name) (urethane adhesives, CosMED Pharmaceuticals).

[0050] The adhesive is directly applied to the substrate for use, but especially when applied to the oral cavity, because the oral cavity is extremely hydrophilic and the surface contains a large amount of water, sometimes this water will cover the surface of the adhesive and make the adhesive disappear. In order to prevent this situation and achieve long-term stable skin application, it is effective to pre-blend and mix the hydrophilic substance in the adhesive and apply it to the substrate. The hydrophilic substance in the present invention refers to a substance that dissolves or swells when added to water. As a hydrophilic substance, it can be used: low molecular hydrophilic substances such as glucose and glycerol; hydrophilic polymer substances such as polyacrylic acid, hyaluronic acid (sodium salt), carboxymethyl cellulose (sodium salt), polyvinyl alcohol, polyvinyl pyrrolidone, dextrin, sodium chondroitin sulfate, collagen; or cross-linked bodies of hydrophilic polymer substances. In particular, from the viewpoint of adding to a non-aqueous solution such as an acrylic adhesive, a hydrophilic polymer substance is more preferred. The role of the hydrophilic substance is to absorb moisture in the oral cavity so that the adhesiveness as an adhesive is maintained for a longer time. The amount of the hydrophilic substance added is preferably 3 to 80% by mass, more preferably 5 to 70% by mass. If the amount of the hydrophilic substance added is too small, the above effect is difficult to achieve, while if it is too large, the adhesive property as an adhesive is lost and the hydrophilic substance remains on the skin.

[0051] A plasticizer may be added to the adhesive. As the plasticizer, generally used plasticizers may be used, for example, isopropyl myristate, isopropyl palmitate, octyl myristate, octyldodecyl lactate, and the like.

[0052] The base material for applying the adhesive is preferably a flexible film, a foam, or a non-woven fabric from the viewpoint of being suitable for curved parts such as the skin and the oral cavity. In the case where the oral adhesion of the adhesive tape is stabilized by absorbing moisture in the oral cavity, it is more desirable to use a foam or a non-woven fabric, and a water-absorbing material is more preferred. The foam can play the role of preventing the flow of the preparation when covering the application of the ointment, liquid, etc. Since the foam is thicker than the film, the hardness is not required to be too large to avoid discomfort in the oral cavity. If the elastic modulus of the foam is 20kgf / cm 2Below, there will be no discomfort in the oral cavity. For the determination of the elastic modulus, the foam can be punched into a dumbbell shape and measured according to the stress-variation curve when stretched by a tensile testing machine. The foam can be any of a continuous bubble foam and an independent bubble foam. The side in contact with the oral cavity can be porous. Regarding the thickness, if it is a film, it is preferably 300μm or less and 5μm or more (it can also be 100μm or less and 5μm or more), and if it is a foam, it is preferably 10mm or less and 0.1mm or more. If it is a non-woven fabric, it is preferably 20mm or less and 0.05mm or more. More preferably: if it is a film, it is 100μm or less and 10μm or more, and if it is a foam, it is 6mm or less and 0.5mm or more. If it is a non-woven fabric, it is preferably 10mm or less and 0.08mm or more. Regarding the size of the adhesive / substrate, since it is used to fix the micro-protrusion patch, it is preferably a size of 1 to 10mm from the edge of the micro-protrusion patch.

[0053] During actual application, the coating medicine (gel / ointment, etc.) is placed and spread on the micro-protrusion surface to make it planar, then applied to the skin and pressed from the back side of the substrate so that the micro-protrusion patch is close to the skin. The shape of the micro-protrusion patch can be square, rectangular, circular, elliptical, or cylindrical, spherical, etc. If the micro-protrusion patch is lined with an adhesive tape and made to be close to the skin, the closeness is better. In this way, the skin stretches to promote the penetration of the drug in the skin. Even if the skin is pressed with micro-protrusions, as long as the density of the micro-protrusions is high and the length of the micro-protrusions is below 1500 μm, the skin will not be broken to cause bleeding.

[0054] The micro-protrusion patch for oral mucosa is preferably a patch that is rectangular with a short diameter of 15 mm or less and a long diameter of 30 mm or less in order to fit the gums. The thickness of the substrate is preferably 500 μm or less, and particularly preferably 300 μm or less. Furthermore, the substrate is also required to be flexible, and the water-insoluble thermoplastic polymer constituting the substrate is also preferably 1.5×10 4 Kgf / cm 2 The polymer material forming the microprotrusions and the polymer material forming the substrate are preferably the same, but may be different water-insoluble thermoplastic polymer materials as long as the above conditions are satisfied.

[0055] The method for forming the micro-protrusions in the present invention can include: compression molding using a mold, mold molding in which a solution obtained by dissolving a polymer substance in a solvent is filled into a mold and dried, injection molding, etc. When a soft silicone resin or a urethane resin is used as a raw material, the raw material before curing is added to the mold and cured to form a micro-protrusion patch. A thermoplastic resin is placed in a mold, heated and filled, and taken out after cooling.

[0056] Press molding is the easiest. In particular, in order to make the substrate with micro-protrusions thinner and produce a flexible object, press molding using a mold is a more appropriate manufacturing method.

[0057] The microprotrusions are preferably produced by heating and pressing a thermoplastic plastic onto a concave mold, but other methods may also be used to heat and press a thermoplastic onto a metal surface roughened by sandblasting, chemical treatment, laser, etc. The maximum height (Rz) of the concave and convex portions generated by the roughening method is used as the microprotrusion length in the present invention.

[0058] The local anesthetics that can be used in the present invention include lidocaine, mepivacaine, dibucaine, bupivacaine, ropivacaine, procaine, chloroprocaine, tetracaine, benzocaine (ethyl aminobenzoate), and the like.

[0059] Preferred antihistamines include diphenhydramine and salts thereof, chlorpheniramine and salts thereof, isoxipendylate and salts thereof, diphenylpyraline and salts thereof, and benzimidazole and salts thereof.

[0060] Preferred anti-inflammatory, pain-relieving and antipruritic drugs include adrenocortical hormones such as betamethasone ester, nonsteroidal agents such as diclofenac and indomethacin, vitamins for the skin such as vitamin A, and antibacterial agents such as antibiotics.

[0061] The method of use may be: after applying the coating drug to the skin or oral mucosa, the micro-protrusion patch is placed on it in a manner of covering it, and pressed from the back of the substrate. Alternatively, the coating drug may be directly applied to the micro-protrusion surface, applied to the skin or oral mucosa, and then lined with an intraoral adhesive tape.

[0062] Example

[0063] The present invention is described in more detail below by the following examples. These examples are only used to illustrate the present invention in detail, and the scope of the present invention is not limited to these examples.

[0064] The micro-protrusion patch manufactured in this embodiment is: a plurality of micro-protrusions are formed on a sheet substrate, and an adhesive tape (see Figure 1 A to C). Hereinafter, an example of an embodiment in which the microprotrusion patch of the present invention is used for local anesthesia will be described.

[0065] Example 1

[0066] A first embodiment of the microprotrusion patch of the present invention will be described using drawings.

[0067] Figure 1 The micro-protrusion patch shown in B is a patch with multiple micro-protrusions of 700 μm in length standing on a circular substrate. Each protrusion is conical in shape, with a diameter of 35 μm at the tip of the protrusion and a protrusion spacing of 500 μm. Figure 2 As shown in B.

[0068] A 100 μm thick polypropylene sheet was placed on a metal concave mold, heated to 180°C, and then pressed to form a sheet with tiny protrusions. The sheet was cut into 10 mm diameters to produce a micro-protrusion patch. The protrusion length was 700 μm and the thickness of the substrate was 90 μm. The micro-protrusion patch was bonded to a tape cut from a commercially available Band-Aid into 16 mm diameters and then used.

[0069] In order to actually use this micro-protrusion patch, 0.1g of the topical anesthetic "EMLA CREAM" (1g of ointment contains 25mg of lidocaine and 25mg of prilocaine) was spread and placed on the entire surface of the micro-protrusions. In this state, the micro-protrusions with the drug were applied to the upper arms of three volunteers, and the base plate (the back of the micro-protrusions) was pressed to make the ointment and micro-protrusion patch adhere to the skin. After applying to the skin, the tape was peeled off partly every 5 minutes, and the drug application area was gently pressed with a toothpick to self-evaluate whether there was pain. The time when the pain was not felt was 25 minutes, 25 minutes, and 30 minutes for the three volunteers. For comparison, 0.1g of EMLA CREAM was applied to a circular area with a diameter of 1cm on the upper arm skin at the same time, and the time when the pain was not felt was evaluated every 5 minutes. The time when the pain was not felt was 45 minutes, 50 minutes, and 50 minutes for the three volunteers.

[0070] Example 2

[0071] A second embodiment of the microprotrusion patch of the present invention will be described using drawings.

[0072] Figure 1 The micro-protrusion patch shown in A is a patch with multiple micro-protrusions of 300 μm in length standing on a rectangular substrate. Each protrusion is in the shape of a truncated cone, with a diameter of 25 μm at the tip of the protrusion and a protrusion spacing of 500 μm. The microscopic photograph of the micro-protrusions is shown in FIG. Figure 2 As shown in A. A high-density polyethylene sheet with a thickness of 60 μm is placed on a metal concave mold, heated to 150°C, and then pressed to form a sheet with a forest of microprotrusions. The sheet is cut into 10 mm × 20 mm to produce a microprotrusion patch with a microprotrusion length of 300 μm and a substrate thickness of 50 μm. This microprotrusion patch is bonded to a tape cut from a commercially available Band-Aid into 16 × 26 mm and then used.

[0073] In order to actually use this micro-protrusion patch, 0.1g of dental local anesthetic "Hurricaine Gel" (1g of gel ointment contains 200mg of ethyl aminobenzoate) was spread and placed on the entire surface of the micro-protrusion. In this state, the micro-protrusions with the drug were applied to the upper jaw of 3 volunteers, and the base plate (the back of the micro-protrusion) was pressed to make the ointment and the micro-protrusion patch adhere to the skin. After the skin application, the tape was partially peeled off every 5 minutes, and the drug application area was gently pressed with a toothpick to self-evaluate whether there was pain. The time when the pain was not felt was 5 minutes for all 3 volunteers. For comparison, 0.1g of Hurricaine Gel was applied to a circular area with a diameter of 1cm on the upper arm skin at the same time, and the time when the pain was not felt was evaluated every 5 minutes. The time when the pain was not felt for 3 volunteers was 5 minutes, 10 minutes, and 10 minutes.

[0074] Comparative Example 1

[0075] Using hyaluronic acid as the material, a micro-protrusion forest sheet with micro-protrusions of 300 μm in length is formed on a rectangular substrate by casting. The shape of the protrusions is the same as that in Example 2. The sheet is cut into 10 mm × 20 mm to make it, and it is bonded to a "tape" cut into 16 × 26 mm by commercially available Band-Aids and used as a micro-protrusion patch. On this patch, 0.1 g of dental local anesthetic "Hurricaine Gel" (1 g of gel ointment contains 200 mg of ethyl aminobenzoate) is spread and placed on the entire surface of the "micro-protrusion" part.

[0076] When the micro-protrusions were observed after 5 minutes, the hyaluronic acid swelled and dissolved due to the water in the gel, and the shape of the micro-protrusions completely disappeared.

[0077] Example 3-9

[0078] The same 10 mm × 20 mm micro-protrusion patch as that produced in Example 2 was bonded to an adhesive tape cut to 16 × 26 mm and used. 0.1 g of "Hurricaine Gel" (trade name, 1 g of gel ointment contains 200 mg of ethyl aminobenzoate) was spread and placed on the entire surface of the micro-protrusions. Seven types of adhesive tapes were used. The composition of the adhesive and the type of substrate of the adhesive tape used are shown in Table 1.

[0079] The micro-protrusion patches with adhesive tape of Examples 3 to 9 were pressed against the palate, and after 1 minute, each adhesive tape was moved left and right to evaluate the strength of the adhesive tape attached to the palate. The results were classified as follows.

[0080] (1) Moves by sliding on the upper jaw under the push of a light force.

[0081] (2) Although it does not move when pushed lightly, it slides on the upper jaw and moves when pushed more strongly.

[0082] (3) Even with strong push, the adhesion to the upper jaw is strong and does not move.

[0083] (4) If pushed with strong force, part of the polyacrylic acid will remain bonded to the upper jaw.

[0084]

[0085] Embodiment 10, 11

[0086] The same 10 mm × 20 mm micro-protrusion patch as the micro-protrusion patch manufactured in Example 2 was adhered to an adhesive tape cut to 16 × 26 mm and used. 0.2 g of "Hurricaine Gel" (1 g of gel ointment contains 200 mg of ethyl aminobenzoate) was spread and placed on the entire surface of the micro-protrusion. The adhesive of the adhesive tape has the same composition as the adhesive used in Example 7, and the substrate for the adhesive tape is a polyethylene film in Example 10 and a polyurethane foam in Example 11. The two types of micro-protrusion patches with adhesive tapes were pressed against the upper arm of a person, and the overflow of Hurricaine Gel around the adhesive tape was immediately confirmed. Although the overflow of the gel ointment was observed at the edge of the tape in the tape structure of Example 10, the overflow of the gel ointment was not observed around the tape of Example 11. The effect of the polyurethane foam in preventing the flow of the coating drug can be confirmed.

[0087] Example 12

[0088] A high-density polyethylene sheet with a thickness of 50 μm was placed on a metal concave mold with a maximum height of 100 μm on a stainless steel plane by sandblasting, heated to 150°C, and the micro-concave and convex sheet was molded by press molding and cut into 10 mm × 20 mm to produce a micro-concave and convex patch. The maximum height (Rz) of the concave and convex is 90 μm. The micro-concave and convex patch was bonded to a tape cut into 16 × 26 mm from a commercially available Band-Aid and then used. 0.15 g of dental local anesthetic "NEOZALOCAIN PASTE" (1 g of the paste contains 250 mg of ethyl aminobenzoate and 50 mg of diethylaminoethyl p-butylaminobenzoate hydrochloride) was spread and placed on the entire surface of the micro-concave and convex. In this state, the micro-concave and convex patch loaded with the drug was applied to the upper jaw of three volunteers, and the substrate (the back of the micro-concave and convex) was pressed to make the paste and the micro-concave and convex patch fit the skin. Five minutes after the application, the tape was peeled off and the drug application area was gently pressed with a toothpick to evaluate whether there was any pain. None of the three subjects felt any pain.

[0089] Description of Reference Numerals

[0090] 1 small protrusion

[0091] 2 Adhesive tape (film)

[0092] 3 Adhesive tape (foam-like)

Claims

1. A micro-protrusion patch suitable for skin or oral mucosa, wherein: The micro-protrusion patch includes a substrate and micro-protrusions arranged on the substrate. The substrate and the micro-protrusions include a 1.5×10 4 kgf / cm 2 A water-insoluble thermoplastic polymer having an elastic modulus of the following.

2. The microprotrusion patch according to claim 1, wherein: The diameter of the tip of the microprotrusion is 10 μm to 300 μm, the length of the microprotrusion is 50 μm to 1500 μm, and the thickness of the substrate is 20 μm to 500 μm.

3. The microprotrusion patch according to claim 1 or 2, wherein: The water-insoluble thermoplastic polymer is selected from polyolefin, soft silicon and polyurethane.

4. The microprotrusion patch according to any one of claims 1 to 3, wherein The micro-protrusion patch is backed by adhesive tape.

5. The microprotrusion patch according to claim 4, wherein: The adhesive constituting the adhesive tape contains a hydrophilic substance.

6. The microprotrusion patch according to claim 5, wherein: The hydrophilic substance is at least one selected from polyacrylic acid, hyaluronic acid and its sodium salt, carboxymethyl cellulose and its sodium salt, polyvinyl alcohol, polyvinyl pyrrolidone, dextrin, sodium chondroitin sulfate, collagen and cross-linked products thereof.

7. The microprotrusion patch according to claim 4, wherein: The adhesive substrate constituting the adhesive tape is a foamed material.

8. The microprotrusion patch according to claim 4, wherein: The adhesive substrate constituting the adhesive tape is a nonwoven fabric.

9. A local application system for shortening the duration of action of a drug on the skin or oral mucosa, comprising the microprotrusion patch according to any one of claims 1 to 8 and a coating drug.

10. The topically applicable system of claim 9, wherein: The medication is a local anesthetic or antihistamine. The topical application system is intended to achieve short-term pain relief or itching relief.

11. The topically applicable system of claim 10, wherein: The local anesthetic is lidocaine or ethyl aminobenzoate.

12. The topically applicable system of claim 10, wherein: The antihistamine is selected from diphenhydramine and its salts and chlorpheniramine and its salts.